Singapore’s co-developed vaccine candidate is in ‘good shape’ for delivery in 2021

Positive results were announced by Singapore's Covid vaccine candidate ARCT-021, developed by Arcturus Therapeutics together with Duke-NUS Medical School.

 

With thanks to our Friends over at : Business News

 

Read the Full Story : Click here